Medical News

RSS

Multiple pain locations contribute to greater knee pain

A new study found that patients with osteoarthritis (OA) of the knee who also have pain in other joints were more likely to experience greater knee pain. Specifically, pain in the lower back as well as foot pain and elbow pain on the same side as the affected knee were associated with more severe knee pain. Full details appear in the December issue of Arthritis Care & Research, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology.

18 Nov 2010

Medivir AB reports positive interim data on Phase 2b ASPIRE study for hepatitis C

Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases announces today positive top-line 24-week interim data from the Phase 2b ASPIRE (C206) study of TMC435 in treatment-experienced hepatitis C patients.

18 Nov 2010

MK-4827 drug candidate shows promising anti-tumour activity in first human trial

A new drug that targets proteins responsible for helping cancer cells to repair damage to their DNA has shown promising anti-tumour activity in its first trial in humans.

18 Nov 2010

EMA reviews CTI's Pixuvri Marketing Authorization Application for NHL

Cell Therapeutics, Inc. announced today that CTI's Marketing Authorization Application seeking approval for Pixuvri (pixantrone dimaleate) for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin's lymphoma was validated and accepted for review by the European Medicines Agency.

18 Nov 2010

Cigarette smoke, automobile exhaust and french fries increase risk of developing Alzheimer's disease

There is growing evidence that exposure to a group of chemicals known as type-2 alkenes -- which are found in the smoke inhaled from cigarettes, the exhaust of automobiles and even in French fries - can increase the chances of developing Alzheimer's disease and other neurological conditions such as Parkinson's disease.

18 Nov 2010

Scientists solve structure of key protein from Lassa virus

Scientists at Emory University and the University of St. Andrews have solved the structure of a key protein from Lassa virus, which is endemic to West Africa and can cause a deadly hemorrhagic fever.

18 Nov 2010

Report plus Great American Smokeout offer reasons to quit, renew tobacco prevention efforts

A new report issued by Blue Cross and Blue Shield of Minnesota (Blue Cross) shows that each year, smoking is responsible for 5,135 deaths in Minnesota and $2.87 billion in excess medical costs to treat diseases caused by smoking. The report, titled "Health Care Costs and Smoking in Minnesota," was completed by Jeffrey Fellows, Ph.D., and a nationally known health economist from the Center for Health Research at Kaiser Permanente Northwest.

18 Nov 2010

Exelixis reports interim data of XL184 for metastatic castration-resistant prostate cancer

Exelixis, Inc. today reported interim data from the cohort of patients with metastatic castration-resistant prostate cancer (CRPC) treated with XL184 in an ongoing phase 2 adaptive randomized discontinuation trial (RDT).

18 Nov 2010

Amsterdam 2010 third quarter total expense increases from EUR 4.4 million to EUR 4.7 million

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today provides its non-audited business update in compliance with the EU transparency directive. This report summarizes material events and AMT's financial position for the third quarter of 2010.

18 Nov 2010

Accentia and Biovest exit Chapter 11 as fully restructured organizations

Accentia Biopharmaceuticals, Inc. announced that, effective today, the Company and its majority-owned subsidiary, Biovest International, Inc., have both successfully completed their reorganizations. Pursuant to their respective Plans of Reorganization approved by the bankruptcy court, Accentia and Biovest have now formally exited Chapter 11 as fully restructured organizations.

18 Nov 2010

UC Berkeley receives $16.5 million to support three research centers to examine children's health

Researchers at the University of California, Berkeley's School of Public Health are getting $16.5 million to support three research centers as part of a federal initiative to examine the environmental factors influencing children's health.

18 Nov 2010

Scientists develop new method for detecting functional sites on proteins

A team led by scientists from The Scripps Research Institute has developed a powerful new method for detecting functional sites on proteins. The technique may have broad applications in basic research and drug development.

18 Nov 2010

First Global Symposium on Health Systems Research kicks off in Switzerland

The First Global Symposium on Health Systems Research bringing together researchers, policymakers and donors kicked off in Montreux, Switzerland, on Tuesday, with some conference attendees calling for African leaders to do more to promote health progress in their countries, PANA/Afrique en ligne reports.

18 Nov 2010

Cholera case confirmed in Dominican Republic; Haitian protestors blame U.N. peacekeeping troops for cholera outbreak

Officials on Tuesday said they had confirmed the first case of cholera in Haiti's neighbor, the Dominican Republic, the Associated Press/Forbes reports

18 Nov 2010

Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

Exelixis, Inc. today reported interim data from the cohort of patients with advanced epithelial ovarian cancer, primary peritoneal, or fallopian tube carcinoma treated with XL184 in an ongoing phase 2 adaptive randomized discontinuation trial (RDT).

18 Nov 2010

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

Merck announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee has advised that the data presented support an indication for GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for the prevention of anal cancer and anal intraepithelial neoplasia (AIN) in both males and females 9 through 26 years of age.

18 Nov 2010

Inovio achieves positive results in Phase I PENNVAX-B study for HIV

Inovio Pharmaceuticals, Inc. , a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has achieved high vaccine-induced response rates and strong magnitude of immune responses in its Phase I clinical study of PENNVAX-B, a DNA vaccine for the prevention of HIV infection.

18 Nov 2010

FAO report highlights 'alarmingly' high food price increases, forecasts food import bills could exceed $1T in 2010

International food import bills could exceed $1 trillion in 2010, the U.N. Food and Agriculture Organization (FAO) said Wednesday in its Food Outlook report, which found that wheat and other food staple prices have increased alarmingly over the past year, the Associated Press reports.

18 Nov 2010

Gore launches new internet cloud-based 3D advanced visualization and decision support system

W. L. Gore & Associates today announced the introduction of the GORE® 3D Imaging System, a new internet cloud-based 3D advanced visualization and decision support system that will change the paradigm of pre-case planning. The revolutionary new system, which is on exhibit at the VEITHsymposium (37th Annual Symposium on Vascular and Endovascular Issues), reflects Gore's ongoing commitment to supporting physicians in making informed treatment decisions.

18 Nov 2010

Clinical trial shows dalfampridine tablets improve walking ability in MS patients

Acorda Therapeutics, Inc. today announced that data from the second of two pivotal dalfampridine extended release tablets Phase 3 clinical trials in multiple sclerosis (MS) were published in the October 2010 edition of Annals of Neurology.

18 Nov 2010

Medical News

Multiple pain locations contribute to greater knee pain

Medivir AB reports positive interim data on Phase 2b ASPIRE study for hepatitis C

MK-4827 drug candidate shows promising anti-tumour activity in first human trial

EMA reviews CTI's Pixuvri Marketing Authorization Application for NHL

Cigarette smoke, automobile exhaust and french fries increase risk of developing Alzheimer's disease

Scientists solve structure of key protein from Lassa virus

Report plus Great American Smokeout offer reasons to quit, renew tobacco prevention efforts

Exelixis reports interim data of XL184 for metastatic castration-resistant prostate cancer

Amsterdam 2010 third quarter total expense increases from EUR 4.4 million to EUR 4.7 million

Accentia and Biovest exit Chapter 11 as fully restructured organizations

UC Berkeley receives $16.5 million to support three research centers to examine children's health

Scientists develop new method for detecting functional sites on proteins

First Global Symposium on Health Systems Research kicks off in Switzerland

Cholera case confirmed in Dominican Republic; Haitian protestors blame U.N. peacekeeping troops for cholera outbreak

Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

Inovio achieves positive results in Phase I PENNVAX-B study for HIV

FAO report highlights 'alarmingly' high food price increases, forecasts food import bills could exceed $1T in 2010

Gore launches new internet cloud-based 3D advanced visualization and decision support system

Clinical trial shows dalfampridine tablets improve walking ability in MS patients

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News